Nova Eye Medical

Nova Eye Medical Ltd is a medical technology company specializing in the development, manufacture, and sale of proprietary ophthalmic treatment technologies and devices. Its primary product, iTrack, is a minimally invasive glaucoma surgery (MIGS) device that restores the eye's natural outflow pathway, lowering intraocular pressure and reducing patient reliance on medications for mild to moderate glaucoma. The company's revenue is predominantly generated from its Glaucoma Surgical Devices segment, with a significant portion coming from global sales to eye surgeons.